MedPath

Identification of proteins and genes involved in proliferative diabetic retinopathy

Completed
Conditions
proliferative diabetic retinopathy. Vessel newgrowth in retina in diabetes
10047060
Registration Number
NL-OMON39671
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients with proliferative diabetic retinopathy who need a vitrectomy.
Controlgroup: Patients (without diabetes mellitus) with a macular hole, a macular pucker or vitreous floaters who need a vitrectomy

Exclusion Criteria

No informed consent
Age >18 years
Legal incapacity
In the control group:
No informed consent
Age >18 years
Legal incapacity
Diabetes mellitus

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary study parameter is presence of to-be-detremined proteins in the<br /><br>vitreous of patients with PDR compared with healthy persons.<br /><br>Furthermore, using microarray analysis, RNA transcripts will be determined that<br /><br>are increased in patients with PDR compared to non-diabetic patients.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath